STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: Orexo AB (STO:ORX) announces today that its partner ProStrakan Group plc (LSE:PSK) has presented its sales figures for Abstral in Europe in a press release. ProStrakan states that sales of Abstral underwent a strong development in 2009 and sales in the range of GBP 5 M – GBP 6 M were achieved for full-year. In ProStrakan’s press release from November 2009, it was stated that sales for the first ten months of 2009 amounted to GBP 3.2 M.
